Research
Evaluating alignment between Canadian Common Drug Review reimbursement recommendations and provincial drug plan listing decisions: an exploratory study
Nicola Allen, Stuart R. Walker, Lawrence Liberti, Chander Sehgal and M. Sam Salek
November 04, 2016 4 (4) E674-E678; DOI: https://doi.org/10.9778/cmajo.20160006
Nicola Allen
School of Pharmacy and Pharmaceutical Sciences (Allen, Walker), Cardiff University, Cardiff, UK; Centre for Innovation in Regulatory Science (Allen, Walker), London, UK; Centre for Innovation in Regulatory Science (Liberti), Hatton Garden, London, UK; Canadian Agency for Drugs and Technologies in Health (Sehgal), Ottawa, Ont.; Department of Pharmacy, Pharmacology and Postgraduate Medicine (Salek), School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK; Institute for Medicines Development (Salek), Cardiff, UK
MPharmPhDStuart R. Walker
School of Pharmacy and Pharmaceutical Sciences (Allen, Walker), Cardiff University, Cardiff, UK; Centre for Innovation in Regulatory Science (Allen, Walker), London, UK; Centre for Innovation in Regulatory Science (Liberti), Hatton Garden, London, UK; Canadian Agency for Drugs and Technologies in Health (Sehgal), Ottawa, Ont.; Department of Pharmacy, Pharmacology and Postgraduate Medicine (Salek), School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK; Institute for Medicines Development (Salek), Cardiff, UK
PhDLawrence Liberti
School of Pharmacy and Pharmaceutical Sciences (Allen, Walker), Cardiff University, Cardiff, UK; Centre for Innovation in Regulatory Science (Allen, Walker), London, UK; Centre for Innovation in Regulatory Science (Liberti), Hatton Garden, London, UK; Canadian Agency for Drugs and Technologies in Health (Sehgal), Ottawa, Ont.; Department of Pharmacy, Pharmacology and Postgraduate Medicine (Salek), School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK; Institute for Medicines Development (Salek), Cardiff, UK
MSRPhChander Sehgal
School of Pharmacy and Pharmaceutical Sciences (Allen, Walker), Cardiff University, Cardiff, UK; Centre for Innovation in Regulatory Science (Allen, Walker), London, UK; Centre for Innovation in Regulatory Science (Liberti), Hatton Garden, London, UK; Canadian Agency for Drugs and Technologies in Health (Sehgal), Ottawa, Ont.; Department of Pharmacy, Pharmacology and Postgraduate Medicine (Salek), School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK; Institute for Medicines Development (Salek), Cardiff, UK
MDMBAM. Sam Salek
School of Pharmacy and Pharmaceutical Sciences (Allen, Walker), Cardiff University, Cardiff, UK; Centre for Innovation in Regulatory Science (Allen, Walker), London, UK; Centre for Innovation in Regulatory Science (Liberti), Hatton Garden, London, UK; Canadian Agency for Drugs and Technologies in Health (Sehgal), Ottawa, Ont.; Department of Pharmacy, Pharmacology and Postgraduate Medicine (Salek), School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK; Institute for Medicines Development (Salek), Cardiff, UK
PhD
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Evaluating alignment between Canadian Common Drug Review reimbursement recommendations and provincial drug plan listing decisions: an exploratory study
Nicola Allen, Stuart R. Walker, Lawrence Liberti, Chander Sehgal, M. Sam Salek
Nov 2016, 4 (4) E674-E678; DOI: 10.9778/cmajo.20160006
Related Articles
Cited By...
- No citing articles found.